Rationale: Drosophila has been recognized as a model to study human cardiac diseases. Objective: Despite these findings, and the wealth of tools that are available to the fly community, forward genetic screens for adult heart phenotypes have been rarely performed because of the difficulty in accurately measuring cardiac function in adult Drosophila.
M ammalian animal models are useful to investigate the molecular pathways and pathophysiology of cardiomyopathy. However, genetic screens in mammalian models are complicated by time and effort required to identify the gene responsible for disease-related phenotypes. [1] [2] [3] As a model system of human diseases, Drosophila has several advantages including efficient genetic screening and mapping, a wellannotated genome, transposon insertion and molecularlydefined genomic deficiency stocks, and conserved signaling pathways. 4 -7 Additionally, the fruit fly has been recognized as a model to study human cardiac diseases. 6, 8 The adult Drosophila heart develops from the embryonic dorsal vessel and shares similarities with vertebrate myocardium. 9 -11 For example, alterations in structural proteins such as troponin I, tropomyosin, ␦-sarcoglycan, and dystrophin result in impaired Drosophila cardiac function. 8, [12] [13] [14] Moreover, mutations in ion channels including the potassium channel genes KCNQ and HERG result in increased arrhythmia index and shortened lifespan. [15] [16] [17] Additionally, transcription factors including Tin/Nkx2.5, Twist, Mef, and Hand have been identified in Drosophila and have orthologs that are critical to vertebrate heart development. 6,18 -20 Despite these findings, and the wealth of tools that are available to the fly commu-nity, forward genetic screens for adult heart phenotypes have been rarely performed because of the difficulty in accurately measuring cardiac function in adult Drosophila. Recently, we developed a strategy to obtain rapid and accurate real-time measurements of cardiac function in the awake adult fly by optical coherence tomography (OCT). 8 Using OCT, we performed a screen of adult flies that have genomic deficiencies and identified a novel gene, CG31665 that has structural similarities to members of the Notch family.
In Drosophila, Notch signaling is essential for cell differentiation and tissue development. 21, 22 The membrane-spanning Notch receptor is stimulated by the ligands Delta (Dl) or Serrate (Ser), which are present on the surface of neighboring cells. After ligand binding, presenilin proteins mediate proteolytic cleavage of the Notch Intracellular domain (NICD). 21, 23 Subsequently, the cleaved NICD undergoes nuclear translocation, where it functions as a transcriptional coactivator for the Su(H) (suppressor of Hairless) transcription factor, resulting in the expression of specific target genes such as E(spl) (enhancer of split). This activation is strictly controlled, and deregulation causes extreme developmental defects. 24 -27 The stringency of the control system is provided by the general Notch antagonist Hairless that assembles in a repressor complex on Notch target genes. 21, 22 Although Notch signaling is crucial in the development of many different Drosophila tissues including the heart, 22,28 -32 the role of Notch signaling in adult Drosophila cardiac function is unknown. In mammals, Notch signaling regulates many aspects of embryonic development, tissue homeostasis, and disease. [33] [34] [35] [36] In both humans and mice, mutations in components of the Notch signaling pathway play a role in the development of a number of congenital cardiovascular diseases. 33, 37 Here, we identified a new gene that when deleted causes dilated cardiomyopathy. The phenotype observed in deletion mutants of CG31665 is consistent with a tired or fatigued heart, and therefore we name the gene weary (wry). We show that Wry functions as a Notch ligand, but is structurally distinct from Dl and Ser. We further show that Notch signaling is critically important for the maintenance of normal heart function of the adult fly.
Methods
Molecular-defined genomic deficiency strains and transposon insertion stocks were obtained from the FlyBase repository at Bloomington, IL and PiggyBac insertion mutants were obtained from the Exelixis repository at Harvard Medical School. Transgenic RNA interference (RNAi) strains were obtained from the Vienna Drosophila RNAi Center.
Detailed descriptions of fly stocks, cardiac measurements in adult Drosophila, quantitative RT-PCR, imaging wings, Drosophila cell culture and cell aggregation assays, ligand-dependent luciferase assay, and statistical analysis are provided in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Identification of a Haploinsufficient Region on Chromosome 2L That Causes Dilated Cardiomyopathy in Adult Drosophila
We used OCT to measure heart function in a screen of adult Drosophila with molecularly-defined genomic deficiencies along chromosome 2L. We identified a deletion mutant, Df(2L)Exel7007, with the phenotype of dilated cardiomyopathy defined as enlarged end-diastolic and end-systolic dimensions, and impaired fractional shortening ( Figure 1A and 1B). This mutant is haploinsufficient for a 193kb genomic region corresponding to 22B1-22B5 on chromosome 2 and covers 23 annotated genes.
To narrow down the candidate gene interval responsible for the cardiomyopathic phenotype of Df(2L)Exel7007, we examined 3 overlapping deletion stocks. Df(2L)Exel8005 had a dilated phenotype that was similar to Df(2L)Exel7007 and allowed us to narrow the candidate interval to 16 genes ( Figure  1C through 1E).
Because the majority of homozygous deletions are lethal, deficiency stocks are maintained as heterozygotes in the presence of a balancer chromosome. Because the cardiomyopathic phenotype in Df(2L)Exel7007 and Df(2L)Exel8005 could be theoretically attributed to the balancer chromosome, we tested both deficiency strains in the context of w 1118 to remove the possible contribution of the balancer to cardiac dysfunction. Both stocks retained the abnormal cardiac phenotype in the absence of balancer chromosomes (Online Figure I , A through C), supporting our interpretation that a gene deletion in Df(2L)Exel7007 is causative for a cardiomyopathic phenotype in the fly.
Transposon Insertions f00122 and 22697 Identify CG31665 As a Cardiomyopathy Candidate Gene
To narrow the 130-Kb genomic region that included the 16 candidate genes, we examined heart function in seven transposon insertion lines within the genomic region. Of the seven insertion lines screened, we identified 2 stocks (f00122 and 22697) that phenocopied the original deletion Df(2L)Exel7007 ( Figure 1F and 1G). The remaining five insertion lines inserted outside the CG31665 gene had a normal cardiac phenotype ( Figure 1F and 1G and data not shown).
Because both f00122 and 22697 are inserted in the gene CG31665, we examined CG31665 gene expression by quantitative RT-PCR in Df(2L)Exel7007, Df(2L)Exel8005, f00122, and 22697. All 4 stocks displayed a reduction in CG31665 expression ( Figure 1H ). Additionally, f00122 had normal expression levels of 2 neighboring genes (c-cup and CG31663), whereas the 2 deficiency stocks showed reduced expression of c-cup and CG31663 as expected (data not shown).
To validate that the piggyBac transposon insertion altered cardiac function through its effect on CG31665, we excised the piggyBac element from f00122 using precise excision. 38 Precise excision of the piggyBac element resulted in full restoration of normal heart function (Online Figure I, E) . These data suggest that f00122 and 22697 interrupt the gene CG31665 and that CG31665 is the gene responsible for the dilated cardiac phenotype in Df(2L)Exel7007 and Df(2L)Exel8005.
Transgenic Drosophila Harboring RNAi Directed Against CG31665 Have Dilated Cardiomyopathy
We next obtained transgenic Drosophila strains that contain UAS-RNAi targeted to genes within the candidate interval. We crossed each stock with Gal4 driver lines using tinC, actin or hsp70 promoters and evaluated heart function in the F1 generation. To test whether knocking down CG31665 would result in a cardiomyopathic phenotype, we crossed UAS-CG31665RNAi flies with the various Gal4 driver lines. Actin or tinC promoter-induced CG31665 RNAi expression resulted in abnormal cardiac function (Figure 2A and 2B ). 
Non-standard Abbreviations and Acronyms
Su(H) suppressor of Hairless
Using quantitative real-time RT-PCR, we confirmed that UAS-CG31665RNAi flies with actin-Gal4 had decreased CG31665 expression compared to w 1118 controls ( Figure 2C ). Because the expression of the CG31665 RNAi transgene was under the control of Gal4 drivers that are expressed early during Drosophila development, we wanted to eliminate the possibility that the abnormal heart function observed resulted from altered gene expression during embryogenesis. To test whether knocking down CG31665 gene expression postdevelopmentally causes dilated cardiomyopathy, we engineered w;p{tub-Gal80 ts };p{tinC⌬ 4-Gal4}/p{UAS-CG31665RNAi} flies based on the temperature-sensitive Gal80 protein in the context of the bipartite Gal4/UAS transgenic expression system in Drosophila using the cardiac-specific driver, tinC⌬4-Gal4. 39 -43 The Gal80 ts protein is functional at 18°C and binds to Gal4 thereby preventing Gal4 binding to a UAS-CG31665RNAi transgene. However, at 26°C, the Gal80 ts /Gal4 complex dissociates and Gal4 then binds to the UAS-CG31665RNAi to activate its transcription. 39, 41 A temperature shift from 18°C to 26°C resulted in the deterioration of cardiac function that was corrected by a second temperature shift back to 18°C (Figure 2 D and 2E ). These data suggest that postdevelopmental loss of expression of CG31665 in adult fly heart results in inducible and reversible dilated cardiomyopathy. Similar data were found using hsp70 promoter to induce CG31665 RNAi expression (Online Figure II , A through C). We also examined other RNAi lines in our candidate interval and show that cardiac induced RNAi expression for these other genes has no effect on cardiac function (Online Figure III) . Lastly, we used the Gal80 ts /Gal4 temperature-sensitive system for a UAS-RNAi line targeting a neighboring gene (c-cup) and showed no change in cardiac function with temperature shift (data not shown). These data demonstrate that CG31665 is the causative gene responsible for the dilated cardiomyopathic phenotype of Df(2L)Exel7007, and we named this gene weary (wry).
Expression of Recombinant Wry Restores Cardiac Function in the Deletion Mutant Df(2L)Exel7007
To demonstrate that wry is directly responsible for the cardiomyopathic phenotype, we examined the ability of cardiac-specific expression of Wry to rescue the cardiac abnormality in Df(2L)Exel7007. Expression of Wry in the heart completely rescues the abnormal cardiac function of Df(2L)Exel7007 supporting our conclusion that wry is the causative gene ( Figure 2F and 2G ).
Disrupting Components of the Notch Signaling Pathway Causes Dilated Cardiomyopathy
We performed bioinformatic analyses of Wry using the Stockholm Bioinformatics Centre InParanoid Figure IV ), suggesting that it may be involved in Notch signaling. To determine the transcriptional pattern of wry expression, we performed quantitative RT-PCR analysis and show that wry is expressed in all 4 life stages and parallels the expression pattern of the known Notch ligand Ser (Online Table I and Online Results). We next examined the heart function in w;p{tub-Gal80 ts };p{tinC⌬4-Gal4} flies harboring p{UAS-Dl.DN(dominant-negative)} or UAS-Ser.DN to determine whether Notch signaling is important for post developmental cardiac function. Temperature shift from 18°C to 26°C resulted in deterioration in cardiac function and a second temperature shift back to 18°C restored normal function (Figure 3 ). We examined deficiency stocks for Notch signaling components and observed that stocks with deficiencies of Notch ligands or Su(H) had abnormal cardiac function (Online Figure V, A and B) . Additionally, we observed that the cardiac-specific expression of RNAi directed against Notch receptor and ligands caused abnormal cardiac function (Online Figure V , C and D and data not shown). Because mutants in Notch signaling regulators often have wing phenotypes, 44, 45 we next examined the wings of Df(2L)Exel7007. Interestingly, Wry deficiency stocks had normal appearing wings (Online Figure V, E) . These data support our hypothesis that disrupting Notch signaling in the adult fly heart can result in an inducible and reversible dilated cardiomyopathy.
Cardiac-Specific Expression of Notch Signaling Components Rescues the Abnormal Phenotype of Df(2L)Exel7007
Because wry appears to be the causative gene for the phenotype of Df(2L)Exel7007, and may be involved in Notch signaling, we tested whether specific components of the Notch pathway can rescue Df(2L)Exel7007. The introduction of a Notch transgene driven by a cardiac-specific promoter into the context of Df(2L)Exel7007 deletion restored normal cardiac function ( Figure 4A and 4B) . Additionally, cardiacspecific expression of Notch ligands rescued the abnormal phenotype of Df(2L)Exel7007 (Figure 4C through 4F) . Finally, cardiac-specific expression of Su(H), a positive regulator of Notch signaling, rescued the abnormal phenotype of Df(2L)Exel7007, whereas the Notch antagonist Hairless, a negative regulator of Notch signaling, did not restore normal cardiac function ( Figure 5A through 5D) .
To demonstrate the specificity of Wry in restoring abnormal cardiac function, we show that transgenic flies harboring either human ␦-sarcoglycan (Dsg) or fly Medea, a positive regulator of BMP signaling, 46 is unable to restore normal cardiac function in Df(2L)Exel7007 (Online Figure VI) .
Wry Functions As a Notch Ligand
Because cardiac-specific expression of Notch ligands rescued the abnormal phenotype of Wry deficiency stocks, we hypothesized that Wry acts as a functional Notch ligand. To test this hypothesis, we conducted cell-aggregation assays with cells expressing Notch, Dl, Ser, or Wry and examined the ability of Notch to bind different ligands. Confocal images of immunofluorescent cells containing Dl, Ser, or Wry indicate that these proteins are each able to promote cellular adhesion with Notch expressing cells as shown by the clustering of ligand and receptor at sites of cellular contact ( Figure 6A ). Dl, Ser, and Wry induced approximately 20% to 35% cell aggregation compared to Ͻ5% in Notch only containing cells ( Figure 6B ). Next, we examined whether Wry activates downstream nuclear transcription by performing liganddependent Notch-activity reporter assays using S2 cells. We transfected S2N cells with the reporter construct, previously shown to be responsive to transactivation by Dl. 47 When S2N cells were mixed with S2 cells overexpressing Wry, promoter activity was transactivated by approximately 3-fold compared with those mixed with untransfected cells ( Figure 6C ). As a positive control, cells overexpressing Dl or Ser mixed with S2N cells showed a 4 to 5 fold increase in promoter activity. Importantly, Wry-mediated transactivation of Notch was blocked by the ␥-secretase inhibitors, compound E and DAPT ( Figure 6C ). Interestingly, it does not appear that Wry can transactivate Notch signaling in mammalian C2C12 cells (Online Figure VII and Online Results). Collectively, our results suggest that Wry functions as a Notch ligand in Drosophila to induce cleavage of Notch and effectively activate transcriptional events in response to Notch signaling.
Cardiac-Specific Expression of Wry Rescues the Abnormal Phenotype of SerRNAi Flies
Because in vitro cell adhesion assays ( Figure 6 ) and in vivo rescue studies ( Figure 4C through 4F) suggest that Wry acts as a Notch ligand, we tested whether Wry can rescue the abnormal cardiac function in Ser loss-of-function mutants. The cardiac-specific expression of a wry transgene into the context of SerRNAi restored normal cardiac function. In contrast, we show that the expression of Wry by a wingspecific vgMQ promoter did not rescue the wing morpholog-ical abnormalities associated with SerRNAi flies, whereas Ser restored both the cardiac and the wing phenotype in the context of SerRNAi (Figure 7) . These results suggest that Wry functions as a novel Notch ligand in a somewhat tissue-specific manner.
Discussion
In this study, we have identified wry as a gene associated with dilated cardiomyopathy in adult Drosophila through the examination of Drosophila mutants that have genomic haploinsufficiencies, transposon insertions, or cardiac-specific RNAi expression. The protein encoded by wry has motifs that include EGF repeats and a transmembrane domain consistent with the Notch family of proteins but lacks a DSL domain. Using cell aggregation assays and ␥-secretase inhibitors, we show that Wry is a novel Notch ligand that can mediate cellular adhesion with Notch expressing cells and transactivate Notch to promote signaling and nuclear transcription.
Notch signaling is important in directing the specification of tissues including the heart in almost all developmental stages in Drosophila. 22, 28, 29, 31, 32 There are 2 types of Notch ligands, which correspondingly activate distinct signaling mechanisms. 48 -50 Typical Notch ligands, which include Ser and Dl in Drosophila and Jagged 1 to 2 and Dl-like 1, 3, and 4 in mammals, contain a DSL domain and transduce canonical Notch signaling pathway to the CSL (CBF1/suppressor of Hairless/Lag-1)-NICD-Mastermind complex for the maintenance of stem or progenitor cells through transcriptional activation of Notch target genes such as E(spl) in Drosophila and HES1 in mammals. 35, [51] [52] [53] In contrast, atypical Notch ligands like DNER, F3/Contactin and NB-3 in mammals have no DSL domain, and transduce noncanonical Notch signaling to the CSL-NICD-Deltex complex for the differentiation of progenitor cells through MAG transcriptional activation. 48 -50 Notch signals are transduced to the canonical pathway (CSL-NICD-Mastermind signaling cascade) or the noncanonical pathway (CSL-NICD-Deltex signaling cascades) based on the expression profile of Notch ligands, Notch receptors, and Notch signaling modifiers. 36 Interestingly, Wry does not have a DSL domain although Wry does share EGF domain homology with the 2 Drosophila Notch ligands.
Our results suggest that Wry regulates Notch signaling in a DSL domain-independent manner which has not been previously recognized to occur in Drosophila. Interestingly, the identification of Notch signaling in normal adult Drosophila cardiac function has not been previously described. Our results show that the cardiac-specific expression of Notch ligands can rescue the abnormal cardiac phenotype observed in Df(2L)Exel7007, supporting the concept that Wry functions as in the Notch pathway. Interestingly, Df(2L)Exel7007 does not have abnormal wing vein morphology, a phenotype that is associated with deficiency mutants for Notch ligands. 44, 45, 54 In addition, Df(2L)Exel7007 does not possess the characteristic abnormalities in external sensory organs including bristle morphology defects (data not shown) that have previously been identified in mutations of Notch regulators. 55, 56 These results are consistent with a recent study that used genome-wide RNAi screens of Notch signaling and showed no apparent abnormalities in wing vein morphology or external sensory organs in flies that expressed UAS-CG31665RNAi under the control of a pnr (notum specific)-Gal4 or MS1096 (wing-specific)-Gal4 driver. 30 In general, an identification of abnormalities that cause dilated cardiomyopathies in adult Drosophila requires a distinction between mutations that alter heart formation from postdevelopmental effects on cardiac function. During larval stages, the Drosophila cardiovascular system is composed of a dorsal vessel containing 52 pairs of cardiomyocytes that display both endothelial and muscle cell characteristics. The cardiomyocytes form a tubular structure flanked by pericardial cells. 9, 10 Abnormal cardiac function in adult Drosophila can result from defects in embryonic dorsal vessel development mimicking congenital abnormalities 20 and abnormalities arising in postdevelopment. To address this issue we used a temperature sensitive Gal80 ts system to drive expression of UAS-WryRNAi, Dl.DN, and Ser.DN in the fully developed adult fly heart. The transgene expression in tinC-expressing cells could have effects on cardiomyocytes in an autonomous manner, or could affect neighboring cells to influence heart function in a nonautonomous manner. Indeed, nonautonomous influence of the epi-/pericardial cells on the function of the fly heart has been postulated. 57, 58 However, in both cases, our results demonstrate that the inhibition and subsequent restoration of Notch signaling results in the induction and reversal of abnormal cardiac function, respectively. Thus, the regulation of Notch signaling appears to be an important component in the maintenance of normal cardiac function in the adult fly. In mammals, Notch signaling is involved in many aspects of development and disease. [33] [34] [35] [36] Although human mutations in Notch signaling and mutant mouse Arrows represent the clustering of ligand and receptor at sites of cellular contact. B, Graph shows the percentage of total Notchexpressing cells bound to cells that express different proteins or control cells. C, Relative induction of luciferase activity. Control or S2N cells were transfected with a reporter construct 2 X m3-Luc and treated with vehicle only (DMSO) or Compound E or DAPT for 24 hours and then mixed with S2 cells expressing Dl, Ser, or Wry. Activity was measured 4 hours after mixing. Activation of Notch by S2Dl, S2Ser, or S2Wry cells resulted in a significant increase in luciferase signal over controls, which were incubated with control or S2N cells treated with ␥-secretase inhibitors. Data represent meansϮSE of at least 4 independent experiments, each performed in triplicate. *PϽ0.05 vs controls. Original magnification, ϫ150. models of Notch signaling have already been implicated in congenital heart disease, 33, 37 the involvement of Notch signaling in adult cardiac disease remains unclear. Our study suggests that gene orthologs involved in Notch signaling may be important in pathogenesis of mammalian dilated cardiomyopathy and that Notch signaling components may be a therapeutic target for dilated cardiomyopathy. 
